Clinical Trial Update: Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of bortezomib and dexamethasone followed by high-dose melphalan and stem cell transplantation for primary AL amy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)

Snippet

Sponsor: Boston Medical Center | Conditions: Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2017-02-06